Helius Medical Technologies (TSE:HSM) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Helius Medical Technologies and Protech Home Medical, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Helius Medical Technologies | 0 | 0 | 0 | 0 | N/A |
Protech Home Medical | 0 | 0 | 5 | 0 | 3.00 |
Protech Home Medical has a consensus target price of C$2.58, indicating a potential upside of 20.16%. Given Protech Home Medical's higher possible upside, analysts clearly believe Protech Home Medical is more favorable than Helius Medical Technologies.
Profitability
This table compares Helius Medical Technologies and Protech Home Medical's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Helius Medical Technologies | N/A | N/A | N/A |
Protech Home Medical | N/A | N/A | N/A |
Earnings and Valuation
This table compares Helius Medical Technologies and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Helius Medical Technologies | C$661,000.00 | 75.62 | C$-34,262,886.00 | C($14.83) | -1.46 |
Protech Home Medical | C$82.22 million | 2.95 | C$-5,417,568.00 | C($0.05) | -44.79 |
Protech Home Medical has higher revenue and earnings than Helius Medical Technologies. Protech Home Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Protech Home Medical beats Helius Medical Technologies on 5 of the 7 factors compared between the two stocks.